Category: Covid-19 Vaccine

Page 269«..1020..268269270271..280290..»

Updated Guidance on Religious Accommodations to COVID-19 Vaccine Mandates – JD Supra

March 14, 2022

On March 1, 2022, the EEOC updated its guidance on religious accommodations to COVID-19 vaccine mandates. While the guidance states that job applicants and employees have a right to request a religious accommodation from an employers COVID-19 vaccination requirement under Title VII, the new guidance answers many questions specific to COVID-19 vaccination requirements and specifically addresses how employers should evaluate an employees religious objection to the vaccine.

The full updated guidance is available here.

How do employees request a religious accommodation?

Employees must inform their employer of their request to be exempt from the employers COVID-19 vaccination requirement on the basis of their religious observance. When making the request, employees do not need to use any magic words, such as religious accommodation or Title VII. The employee only needs to explain their religious objection to the vaccination requirement.

The guidance states that as a best practice, an employer should provide employees and applicants with information about whom to contact and the proper procedures for requesting a religious accommodation. The EEOC included a link to its own internal workplace form, which its employees can use to request a religious accommodation.

How should an employer evaluate an employees request for a religious exemption to the employers COVID-19 vaccination requirement?

The guidance states that an employer may make a limited factual inquiry and seek additional supporting information from the employee regarding the employees request for a religious accommodation if the employer has an objective basis for questioning the religious nature of the request or the sincerity of the employees asserted religious belief. If an employee does not comply with an employers reasonable requests for verification of the sincerity or religious nature of the request of a professed belief, practice or observance the employee risks losing any subsequent claim that his or her request for a religious accommodation was improperly denied.

Similarly, the employer may ask the employee to explain the religious nature of their belief. This is especially helpful in situations where the employees asserted religious belief is nontraditional or unfamiliar to the employer. However, the employer should not automatically deny a request or assume that it is invalid simply because the employees asserted religion is nontraditional or unfamiliar to the employer.

The guidance further states that Title VII does not protect social, political, or economic views, or personal preferences. Accordingly, an employee who makes a request purely based on a social, political or economic view or based on a personal preference would not be entitled to a religious accommodation. The guidance states that other nonreligious concerns are not protected such as a concern about the possible effects of the vaccine. Employers should be cautious with this approach and should note that there could be overlap between a religious belief and a nonreligious view and that such a belief may still be protected under Title VII.

May employers evaluate whether the asserted religious belief is sincerely held?

Yes. While the guidance states that the employees sincerity in holding a religious belief is typically not in dispute, there are certain factors that may indicate that the belief is not sincerely held. These factors include:

No one factor is determinative and requests should be evaluated on a case-by-case basis.

When would a requested accommodation constitute an undue hardship?

Under Title VII, an employer may deny a request for an accommodation when the accommodation would pose an undue hardship on the employer. Accordingly, before denying a request for a religious accommodation, the employer should assess whether the employer can reasonably grant an accommodation such as remote work or reassignment. The guidance includes a list of possible accommodations that an employer may want to consider for employees requesting a religious accommodation to the COVID-19 vaccination requirement.

However, an accommodation that would require an employer to bear more than a minimal cost is an undue hardship. The guidance expressly states with regards to employees who are unvaccinated against COVID-19, that a cost to consider would include the risk of the spread of COVID-19 to other employees or to the public. Other cost factors include:

The guidance further states certain considerations that are relevant during the COVID-19 pandemic when an employee is requesting a religious accommodation to the COVID-19 vaccination requirement. These include:

The guidance clearly states that the employer does not have to grant all requests for a religious accommodation to the COVID-19 vaccination requirement merely because it grants one request. Whether the religious belief is sincerely held and whether the accommodation would pose an undue hardship should be analyzed on a case-by-case basis. The guidance also states that an employer who grants a request for an accommodation may later re-evaluate the request based on a change in circumstances.

[View source.]

See the original post:

Updated Guidance on Religious Accommodations to COVID-19 Vaccine Mandates - JD Supra

Explained: Centres decision of opening up Covid-19 vaccination for kids in 12-14 age bracket – The Indian Express

March 14, 2022

From Wednesday, kids in the 12-14 age bracket will be able to get their Covid-19 vaccines as the Centre decided to expand its inoculation drive. We take a look at who are eligible for these shots and what vaccines will be used to inoculate the kids.

Subscribe Now: Get Express Premium to access the best Election reporting and analysis

Who are eligible and when will they get their shots?

The Health Ministry announced that those born in 2008, 2009, and 2010, i.e, those who are above the age of 12, will be eligible for their Covid-19 vaccines from March 16.

Currently, the population above 14 years of age are being administered Covid-19 vaccines under the ongoing inoculation programme.

Which vaccines will be used for this age group?

According to the Health Ministry, Corbevax, that is manufactured by the Hyderabad-based Biological-E, will be used to inoculate kids in this age group. Corbevax is Indias first indigenously developed Receptor Binding Domain (RBD) protein sub-unit vaccine. On February 21, Indias drug approval agency granted emergency use authorization to Corbevax for the 12-18 years age group.

What is the technology that Corbevax has been built on?

Corbevax, a protein sub-unit Covid-19 vaccine, is one that is built on the traditional sub-unit vaccine platform. Instead of the whole virus, the platform triggers an immune response by using fragments of it, like the spike protein. The sub-unit vaccine contains the harmless S-protein, and once the human immune system recognises it, it produces antibodies, such as white blood cells, that fight the infection.

Corbevax includes antigenic parts of the virus to trigger a protective immune response. The antigen has been developed by the Texas Childrens Hospital Centre for Vaccine Development and in-licensed from BCM Ventures, Baylor College of Medicines integrated commercialization team.

Newsletter | Click to get the days best explainers in your inbox

Read more:

Explained: Centres decision of opening up Covid-19 vaccination for kids in 12-14 age bracket - The Indian Express

Additional Financing of $25 Million to Boost COVID-19 Vaccine Rollout in Tajikistan with World Bank Support [EN/RU] – Tajikistan – ReliefWeb

March 14, 2022

DUSHANBE, March 14, 2022 The Government of Tajikistan and the World Bank signed a US$25 million grant agreement as additional financing to the Tajikistan Emergency COVID-19 Project, which has been supporting Tajikistans efforts to respond to the health, social and economic impacts of the COVID-19 pandemic since 2020. These additional resources will support the procurement and provision of vaccines against COVID-19. The agreement was signed by the Minister of Finance of Tajikistan Faiziddin Qahhorzoda and World Bank Country Manager Ozan Sevimli.

I am very pleased that with World Bank support, we will be able to help the people of Tajikistan access safe and effective vaccines against COVID-19 and stay healthy and protected, said Ozan Sevimli, World Bank Country Manager to Tajikistan. This is especially critical as the country paves its way towards a more resilient and sustainable post-pandemic recovery and economic growth.

Currently about 53 percent of Tajikistans population has received a single dose of the vaccine and 48 percent have received two doses and are considered to be fully vaccinated. The additional financing will help Tajikistan close its COVID-19 vaccine gap and meet the recently expanded national target of vaccinating all citizen above 12 years of age.

The additional financing will also cover the cost of vaccine delivery, distribution within Tajikistan, the cost of key consumables (needles, syringes, safety boxes), expansion of the electronic vaccine and COVID-19 testing registration system, as well as the printing of vaccine certificates. It will also help procure COVID-19 tests, additional PPE, and supplies such as medications and consumables for hospitals for COVID-19 patients. Additionally, the authorities will be able to expand their communication activities to address vaccine hesitancy and misinformation related to the pandemic.

The original Tajikistan Emergency COVID-19 Project, with a total financing of $11.3 million, was approved in April 2020, and in February 2021 the World Bank approved additional $21.2 million for the project. These resources have helped strengthen Intensive Care Units in 10 hospitals across the country through equipment, medical supplies, personal protective equipment, and small rehabilitation works. Necessary investments were made to improve oxygen supply in 15 hospitals across Tajikistan to help severely ill COVID-19 and other patients to receive life-saving oxygen therapy. As part of the project, a one-time emergency cash assistance was provided to over 214,500 poor households across the country to mitigate the impacts of food price shocks caused by the pandemic. In addition, 650,400 doses of the Moderna vaccines, procured through COVAX, were delivered in early 2022 and important investments were made to prepare Tajikistan for the broader vaccine rollout. The project also provided one-time emergency support to fill a budget gap for procuring vaccines for measles, mumps, and rubella (MMR) for children. The project continues to provide critical support to strengthen national capacity on COVID-19 communication and public outreach, with 50 journalists and over 490 community volunteers trained so far.

Currently, the World Bank is financing 25 projects in Tajikistan totaling at $1.39 billion. Since 1996, the World Bank has provided over $2.44 billion in IDA grants, highly concessional credits, and trust funds for Tajikistan. The World Bank is committed to continuing its support as the country strives to improve the lives and meet the aspirations of its young and growing population.

World Bank Group Response to COVID-19

The World Bank Group is taking broad, fast action to help developing countries strengthen their pandemic response, increase disease surveillance, improve public health interventions, and help the private sector continue to operate and sustain jobs. Since the start of the COVID-19 pandemic, the Bank Group has committed over $157 billion to fight the impacts of the pandemic, the fastest and largest crisis response in its history. The financing is helping more than 100 countries strengthen pandemic preparedness, protect the poor and jobs, and jump start a climate-friendly recovery.

PRESS RELEASE NO: 2022/ECA/68

See original here:

Additional Financing of $25 Million to Boost COVID-19 Vaccine Rollout in Tajikistan with World Bank Support [EN/RU] - Tajikistan - ReliefWeb

Modeling study assesses the effectiveness facemasks before and after COVID-19 vaccination – News-Medical.Net

March 14, 2022

Scientists and healthcare officials have developed several pharmaceutical and non-pharmaceutical interventions to contain the ongoing coronavirus disease 2019 (COVID-19) pandemic. For example, wearing facemasks has been one of the most effective non-pharmaceutical measures that have been adopted globally to prevent the further spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and protect individuals from contracting COVID-19.

Study: Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study. Image Credit: Mr. Tempter / Shutterstock.com

Early on in the COVID-19 pandemic, most people wore facemasks in the United States. However, researchers observed that this practice relaxed since the spring of 2021, even though the vaccination rates were below that which has been projected to attain herd-immunity thresholds.

In mid-May 2021, the U.S. Centers for Disease Control and Prevention (CDC) announced that vaccinated individuals were not required to wear facemasks when they were indoors in public places like restaurants. This prompted both vaccinated and unvaccinated individuals to stop wearing facemasks, which was quickly followed by a significant rise in COVID-19 cases due to the SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variants.

This surge in COVID-19 cases quickly caused local officials to reinstate facemask requirements in Los Angeles County, California, and Washington D.C. Although various studies have shown that facemasks effectively prevent SARS-CoV-2 transmission, the use of facemasks in 2021 remained lower than it was in 2020.

Recently, researchers have addressed some important questions regarding the use of facemasks, such as whether facemasks should be worn in public indoor locations like grocery stores and public transportation, and for how long this practice should be maintained.

In this context, scientists in a recent The Lancet Public Health study simulated different scenarios using facemasks through a computational Monte Carlo simulation model representing the population of the U.S. and SARS-CoV-2 transmission. Moreover, the researchers performed simulations to compare different scenarios, which included predictions of the outcomes for individuals who wore a facemask and those who did not use a facemask until the target vaccination coverage of 70-90% of the population was achieved.

The current study underscored that COVID-19 vaccination alone is not enough to manage the pandemic. Multiple interventions were required to prevent transmission of SARS-CoV-2, death, and suffering.

As each intervention including the frequent use of sanitizers, face masks, and social restrictions is associated with different limitations, a combinational effect of multiple interventions could positively enhance their impact and combat the pandemic.

The authors provided strong evidence that showed the use of facemasks is an effective and cost-effective method to manage the COVID-19 pandemic. The current study also revealed that facemasks must be used continuously, even after reaching specific vaccination coverage levels to attain herd immunity.

Continual use of facemasks is important, as virus transmission does not immediately cease on reaching vaccination threshold levels. In fact, facemasks appear to provide additional prevention until transmission gradually recedes after two to ten weeks.

The decline of vaccine effectiveness as a result of the emergence of new SARS-CoV-2 variants and waning of immune responses induced by vaccination or natural infection have increased the value of wearing facemasks.

The researchers note that it is not realistic to presume that all individuals with COVID-19 would remain isolated for the full duration of their infected phase. This is because many people do not get tested for SARS-CoV-2 infection, asymptomatically infected individuals might transmit infection unintentionally, or some patients might be tempted not to remain isolated throughout the infected phase. This situation further emphasizes the importance of using facemasks to control the pandemic.

The authors recommend that all individuals continue to wear facemasks, irrespective of their age group or profession. When face mask effectiveness was increased by 10%, a relative reduction of 1720% of COVID-19 cases was observed. Additionally, a significant reduction in the number of hospitalizations and deaths due to SARS-CoV-2 infection was reported.

Although the current model is based in the U.S., these findings can resemble similar scenarios in other countries. Furthermore, all models represent a simplified version of real-life conditions and cannot account for every possible outcome.

In the event that there is a shortage of effective facemasks, such as N95 masks, wearing a regular cloth mask is better than not wearing one, as individuals with COVID-19 are less likely to spread the disease when they use facemasks. Taken together, the researchers suggest the continual wearing of facemasks for two to ten weeks beyond achieving specific vaccination coverages to reduce residual SAR-CoV-2 transmission.

View original post here:

Modeling study assesses the effectiveness facemasks before and after COVID-19 vaccination - News-Medical.Net

Coronavirus vaccination rate tops 70% for Ohioans ages 12 and up as COVID cases, hospitalizations continue to – cleveland.com

March 14, 2022

CLEVELAND, Ohio Ohios COVID vaccination campaign like much of the United States has dramatically slowed in recent months. However, the state hit a milestone this past week. About 70% of Ohioans older than 12 years old have at least one vaccine shot.

That figure stood at 70.1%, as of Saturday. When factoring in Ohioans ages 5-11, the figure is 66%, according to the Ohio Department of Health. That is a 0.3% and 0.2% increase week-over-week, respectively.

The vaccination news is just one more bright spot in Ohio, as its other relevant COVID-19 numbers like cases and hospitalizations keep dropping.

The number of reported coronavirus cases in Ohio in the last seven days continues to shrink, down more than 2,000 week-over-week. As of Saturday, that number is 4,380, compared to 6,504 on March 5. Put another way, the figure is a decrease of 32.7% from last weeks total. The seven-day average of cases has subsequently dropped, from 929 to 626. That average hasnt been that low since late July 2021.

The nine consecutive weeks of falling case numbers mean the 21-day average also keeps falling, down to 933 from 1,347 on March 5. The last time the 21-day average of cases was lower than 1,000 was early August 2021.

Additionally, daily COVID hospitalizations in the state keep sliding. Week-over-week, the count was lower on Saturday (631) than it was on March 5 (843); thats a decrease of 212 patients.

The daily patient count for those being treated for COVID-19 in the ICU also steadily dropped over the past week. It was lower Saturday (120) than it was on the prior Saturday (172). Thats a difference of 52.

According to the Ohio Hospital Association, the number of COVID-19 hospitalizations is down 22% over the past seven days; down 60% in the last 21 days and down 90% in the past 60 days. As for COVID-19 ICU admissions, the figure is down 21% over the last seven days; down 64% in the past 21 days and down 90% in the last 60 days.

As of Saturday, 1-in-29 patients hospitalized in Ohio is COVID-positive, the Ohio Hospital Associations data shows, and 1-in-25 ICU patients is COVID-positive.

The weekly reported COVID death count has not consistently fallen, like case and hospitalization figures have. However, in the past four weeks, only one week has seen a report of higher than 1,000.

This week, 392 COVID-19 deaths were reported in Ohio. In the prior four weeks, the count was 438, 1,087, 488 and 788, respectively.

Its worth noting that the death figures often lag for weeks or even months. Ohio reports COVID-19 deaths twice per week, on Tuesday and Fridays.

Starting Monday, the Ohio Department of Health will stop updating its COVID-19 dashboard daily and instead post weekly updates each Thursday. The head of the health department, Dr. Bruce Vanderhoff said last week that officials will continue to monitor the numbers, as well as coronavirus in sewage which can indicate if a spike is coming and could increase reporting if cases or hospitalizations increase.

Read more on cleveland.com:

Most of Ohio goes green on new CDC COVID-19 map; meaning no mask recommendations

Northeast Ohio enjoys second mild flu season in row; COVID-19 measures also slow spread of flu

Gratitude is a daily ritual: Greater Clevelanders reflect on COVID pandemics silver linings after 2 years

Continued here:

Coronavirus vaccination rate tops 70% for Ohioans ages 12 and up as COVID cases, hospitalizations continue to - cleveland.com

COVID-19 Daily Update 3-14-2022 – West Virginia Department of Health and Human Resources

March 14, 2022

The West Virginia Department of Health and Human Resources (DHHR) reports as of March 14, 2022, there are currently 1,244 active COVID-19 cases statewide. There have been 10 deaths reported since the last report, with a total of 6,559* deaths attributed to COVID-19.

*A previously reported death during December 2020 of a 47-year old female from Kanawha County was determined to not be a COVID-19 associated death. Removing this death reduces the cumulative death count by one.

DHHR has confirmed the deaths of a 58-year old female from Cabell County, an 81-year old female from Monongalia County, a 61-year old male from Preston County, an 89-year old male from Lewis County, a 60-year old male from Cabell County, a 78-year old male from Cabell County, an 82-year old female from Lewis County, an 87-year old female from Lewis County, a 79-year old male from Taylor County, and a 90-year old male from Monongalia County.

With a heavy heart, we share this solemn news of more lives lost to this pandemic, and extend our sympathies to the families affected, said Bill J. Crouch, DHHR Cabinet Secretary. Please schedule your COVID-19 vaccine or booster shot today to prevent further loss of life.

CURRENT ACTIVE CASES PER COUNTY: Barbour (9), Berkeley (49), Boone (8), Braxton (16), Brooke (15), Cabell (45), Calhoun (12), Clay (4), Doddridge (1), Fayette (46), Gilmer (5), Grant (6), Greenbrier (32), Hampshire (8), Hancock (8), Hardy (4), Harrison (47), Jackson (10), Jefferson (20), Kanawha (65), Lewis (2), Lincoln (11), Logan (13), Marion (66), Marshall (44), Mason (25), McDowell (35), Mercer (60), Mineral (7), Mingo (21), Monongalia (63), Monroe (8), Morgan (2), Nicholas (22), Ohio (10), Pendleton (2), Pleasants (3), Pocahontas (4), Preston (28), Putnam (34), Raleigh (156), Randolph (9), Ritchie (10), Roane (7), Summers (13), Taylor (13), Tucker (5), Tyler (5), Upshur (26), Wayne (9), Webster (25), Wetzel (20), Wirt (0), Wood (48), Wyoming (28). To find the cumulative cases per county, please visit http://www.coronavirus.wv.gov and look on the Cumulative Summary tab which is sortable by county.

Delays may be experienced with the reporting of information from the local health department to DHHR. As case surveillance continues at the local health department level, it may reveal that those tested in a certain county may not be a resident of that county, or even the state as an individual in question may have crossed the state border to be tested. Please visit http://www.coronavirus.wv.gov for more detailed information.

West Virginians ages 5 years and older are eligible for a COVID-19 vaccine. Booster shots are also available for those 12 and older. To learn more about the vaccine, or to find a vaccine site near you, visit vaccinate.wv.gov or call 1-833-734-0965.

Free pop-up COVID-19 testing is available today in Barbour, Berkeley, Boone, Braxton, Cabell, Clay, Fayette, Gilmer, Greenbrier, Hampshire, Hancock, Jefferson, Lewis, Lincoln, Logan, Marion, Mason, Mineral, Mingo, Monongalia, Monroe, Morgan, Ohio, Putnam, Raleigh, Randolph, Ritchie, Taylor, Tyler/Wetzel, Upshur, Wayne, and Wood counties.

Barbour County

8:30 AM - 3:30 PM, Community Market, 107 South Main Street (across the street from Walgreens), Philippi, WV (optional pre-registration: https://labpass.com/en/registration?access_code=WVBBC)

1:00 PM - 5:00 PM, Junior Volunteer Fire Department, 331 Row Avenue, Junior, WV (optional pre-registration: https://unityphr.com/campaigns/wvlabs/covid)

Berkeley County

8:30 AM - 3:30 PM, Airborne Church, 172 Creative Place, Martinsburg, WV

8:30 AM - 4:00 PM, Shenandoah Community Health, 99 Tavern Road, Martinsburg, WV (optional pre-registration: https://unityphr.com/campaigns/wvlabs/covid)

9:00 AM - 2:00 PM, 891 Auto Parts Place, Martinsburg, WV (optional pre-registration: https://unityphr.com/campaigns/wvlabs/covid)

Boone County

10:00 AM - 3:00 PM, Boone County Health Department, 213 Kenmore Drive, Danville, WV (optional pre-registration: https://wv.getmycovidresult.com/)

Braxton County

9:00 AM - 4:00 PM, Braxton County Memorial Hospital (parking lot), 100 Hoylman Drive, Gassaway, WV (optional pre-registration: https://labpass.com/en/registration?access_code=Braxton)

Cabell County

8:00 AM - 4:00 PM, Marshall University Campus (parking lot), 1801 6th Avenue, Huntington, WV (optional pre-registration: https://wv.getmycovidresult.com/)

8:00 AM - 4:00 PM, Cabell-Huntington Health Department (parking lot), 703 Seventh Avenue, Huntington, WV (optional pre-registration: https://wv.getmycovidresult.com/)

Clay County

8:30 AM - 3:00 PM, Clay County Health Department (parking lot), 452 Main Street, Clay, WV (optional pre-registration: https://labpass.com/en/registration?access_code=WVClayCounty)

Fayette County

10:00 AM - 2:00 PM, Fayette County Health Department, 5495 Maple Lane, Fayetteville, WV

Gilmer County

8:00 AM - 3:00 PM, Minnie Hamilton Health System (parking lot), 921 Mineral Road, Glenville, WV (optional pre-registration: https://labpass.com/en/registration?access_code=WVMHCT11)

Greenbrier County

9:30 AM - 3:00 PM, State Fair of WV, 891 Maplewood Avenue, Lewisburg, WV (optional pre-registration: https://labpass.com/en/registration?access_code=WVGBC)

Hampshire County

10:00 AM - 5:00 PM, Hampshire Memorial Hospital, 363 Sunrise Boulevard, Romney, WV (optional pre-registration: https://unityphr.com/campaigns/wvlabs/covid)

Hancock County

1:30 PM - 3:30 PM, Hancock County Health Department, 100 North Court Street, New Cumberland, WV (optional pre-registration: https://roxbylabs.dendisoftware.com/patient_registration/)

Jefferson County

9:00 AM - 5:00 PM, Hollywood Casino, 750 Hollywood Drive, Charles Town, WV (optional pre-registration: https://unityphr.com/campaigns/wvlabs/covid)

Lewis County

8:00 AM - 3:00 PM, City Parking Lot, 95 West Second Street, Weston, WV (optional pre-registration: https://labpass.com/en/registration?access_code=WVMavLewis1)

Lincoln County

9:00 AM - 3:00 PM, Lincoln County Health Department, 8008 Court Avenue, Hamlin, WV (optional pre-registration: https://wv.getmycovidresult.com/)

Logan County

12:00 PM - 5:00 PM, Old 84 Lumber Building, 100 Recovery Road, Peach Creek, WV (optional pre-registration: https://unityphr.com/campaigns/wvlabs/covid)

10:00 AM - 2:00 PM, Tracy Vickers Community Center, 68 Boise Street, Chapmanville, WV

Marion County

10:00 AM - 6:00 PM, Dunbar School Foundation, 101 High Street, Fairmont, WV

Mason County

8:30 AM - 3:00 PM, Krodel Park, 1186 Charleston Road, Point Pleasant, WV (optional pre-registration: https://labpass.com/en/registration?access_code=WVMavCOUNTY12)

Mineral County

10:00 AM - 4:00 PM, Potomac State College, Church McKee Art Center, 101 Fort Avenue, Keyser, WV

Mingo County

9:00 AM - 3:00 PM, Matewan Volunteer Fire Department, 306 McCoy Street, Matewan, WV (optional pre-registration: https://labpass.com/en/registration?access_code=WVMGC)

Monongalia County

7:00 AM - 9:00 AM, WVU Recreation Center (lower level), 2001 Rec Center Drive, Morgantown, WV

Monroe County

9:00 AM - 2:00 PM, Appalachian Christian Center, 2812 Seneca Trail South, Peterstown, WV

Morgan County

8:30 AM - 3:30 PM, The Blue (of First United Methodist Church), 440 Fearnow Road, Berkeley Springs, WV (optional pre-registration: https://labpass.com/en/registration?access_code=WVMavMorgan1)

11:00 AM - 5:00 PM, War Memorial Hospital, 1 Health Way, Berkeley Springs, WV (optional pre-registration: https://unityphr.com/campaigns/wvlabs/covid)

Ohio County

9:00 AM - 3:30 PM, Ohio Valley Medical Center (back parking lot at the top of 22nd Street), 2000 Eoff Street, Wheeling, WV (optional pre-registration: https://roxbylabs.dendisoftware.com/patient_registration/)

Putnam County

9:00 AM - 5:00 PM, Putnam County Health Department (behind Liberty Square), 316 Putnam Village Drive, Hurricane, WV (optional pre-registration: https://wv.getmycovidresult.com/)

Raleigh County

9:00 AM - 4:00 PM, Beckley-Raleigh County Health Department, 1602 Harper Road, Beckley, WV (optional pre-registration: https://labpass.com/en/registration?access_code=MavBeckleyRaleigh)

Randolph County

8:30 AM - 3:30 PM, Randolph-Elkins Health Department (parking lot), 32 Randolph Avenue, Elkins, WV (optional pre-registration: https://labpass.com/en/registration?access_code=WVRDC)

Ritchie County

1:00 PM - 4:00 PM, Ritchie Regional, 135 South Penn Avenue, Harrisville, WV

Taylor County

2:00 PM - 4:00 PM, Grafton-Taylor Health Department, 718 West Main Street (parking lot at Operations Trailer), Grafton, WV (optional pre-registration: https://wv.getmycovidresult.com/)

Tyler/Wetzel Counties

10:00 AM - 12:00 PM, Wetzel-Tyler Health Department, 425 South Fourth Avenue, Paden City, WV

Upshur County

8:30 AM - 3:30 PM, Buckhannon Fire Department (parking lot), 22 South Florida Street, Buckhannon, WV (optional pre-registration: https://labpass.com/en/registration?access_code=WVUSC)

Wayne County

10:00 AM - 2:00 PM, Wayne County Health Department, 217 Kenova Avenue, Wayne, WV (optional pre-registration: https://unityphr.com/campaigns/wvlabs/covid)

Wood County

8:00 AM - 3:00 PM, Vienna Baptist Church, 3401 Grand Central Avenue, Vienna, WV (optional pre-registration: https://labpass.com/en/registration?access_code=WVMavWood1)

Please check with the testing site, DHHRs social media pages and the COVID-19 website https://dhhr.wv.gov/COVID-19/pages/testing.aspx for any last minute cancellations, and to find other free testing opportunities across West Virginia.

Link:

COVID-19 Daily Update 3-14-2022 - West Virginia Department of Health and Human Resources

COVID-19 Vaccine to be Offered at Weekly County Vaccination Clinics – Oswego County

March 12, 2022

OSWEGO COUNTY The Oswego County Health Department continues to offer COVID-19 vaccines for county residents and is integrating the service into weekly vaccination clinics.

Since early last year, Oswego County Health Department staff have held vaccination clinics at sites in every corner of the county to make the COVID-19 vaccine easily accessible for residents. Those efforts have resulted in nearly 23,000 shots administered by Oswego County Health Department staff.

Through collaborations with state and community partners, more than 70,000 one- or two-dose vaccine regimens have been completed and more than 40,000 of those individuals have received booster or third dose vaccinations.

With a majority of the county vaccinated, health staff are transitioning to include the COVID-19 vaccine as part of weekly vaccine clinics offered at the Nick Sterio Public Health Clinic in Oswego. Anyone seeking the COVID-19 vaccine, or other general immunizations, should call the Oswego County Health Department at 315-349-3547 or schedule a COVID-19 vaccine online.

To view a list of upcoming clinics and schedule an appointment, go to health.oswegocounty.com/vaccines and scroll down to the calendar to click on the date and dose needed.

The following upcoming clinics are scheduled:

Tuesday, March 15

12:30-3:30 p.m. Nick Sterio Public Health Clinic, 70 Bunner St., Oswego

Wednesday, March 16

3:30-5:30 p.m. Nick Sterio Public Health Clinic, 70 Bunner St., Oswego

Tuesday, March 22

12:30-3:30 p.m. Nick Sterio Public Health Clinic, 70 Bunner St., Oswego

Wednesday, March 23

3:30-5:30 p.m. H. Douglas Barclay Courthouse, 1 Broad St., Pulaski

Saturday, March 26

11 a.m. - 2 p.m. SUNY Oswego Marano Campus Center, 55 Rudolph Road, Oswego

Tuesday, March 29

12:30-3:30 p.m. Nick Sterio Public Health Clinic, 70 Bunner St., Oswego

Wednesday, March 30

3:30-5:30 p.m. Nick Sterio Public Health Clinic, 70 Bunner St., Oswego

At-home COVID-19 test kits will be distributed to individuals who are vaccinated at upcoming clinics. Test kits will be distributed while supplies last.

Face masks are required at all health care settings regulated by the state Department of Health, including the Oswego County Health Department and any vaccination site.

For more information, go to the Oswego County Health Departments COVID-19 page at health.oswegocounty.com/covid-19 or call the COVID-19 hotline at 315-349-3330.

Residents should contact their medical providers directly for personal medical advice related to COVID-19 vaccinations, booster shots or treatments.

Under New York State Public Health Law, the Oswego County Health Department is the local public health authority regarding the COVID-19 pandemic response within the County of Oswego. The Oswego County Health Department works closely with New York State Department of Health regarding COVID-19 monitoring, response, and reporting.

Read this article:

COVID-19 Vaccine to be Offered at Weekly County Vaccination Clinics - Oswego County

Malawi marks one year of COVID-19 vaccination, 828, 080 people receive full dose – WHO | Regional Office for Africa

March 12, 2022

Lilongwe, 11 March 2022One year ago today, Malawi launched a COVID-19 vaccination campaign with vaccine doses it received from the COVAX Facility.

To date, 1,955,495 million doses of COVID-19 vaccine have been administered and an estimated 4.4% of the total population has been fully vaccinated. Efforts are underway to increase vaccine uptake to reach a wider proportion of the population.

Since the first shipments, the country has now received a total of 4,469,720 million COVID-19 vaccine doses; 55% (2,459,820 doses) of these from COVAX, 16% (706,800 doses) from the African Vaccine Acquisition Trust (AVATT), and 29% (1,303,100 doses) from bilateral deals and donations. Starting with one vaccine type Astrazeneca Malawi is now offering COVID-19 vaccination with three vaccines Astrazeneca, Janssen, and Pfizer

Malawi rolled out the COVID-19 vaccine in a phased approach, starting with health care workers and other priority groups which included, immigration officers, National Defense Forces, prison warders, prisoners, teachers, those 60 years old and above, and people with underlying health conditions. However, the vaccine roll-out was challenged at several levels, resulting in low uptake.

According to World Health Organization social listening survey, there was vaccine hesitancy due to misinformation, disinformation, and lack of general knowledge about the COVID-19 vaccines. Malawi also faced vaccine supply chain challenges, including a delay in vaccine supply, which resulted in COVID-19 vaccine stockout at the peak of the third wave - this setback was a missed opportunity to increase the number of vaccinated population. Malawi also experienced health system pressures to deliver multiple vaccine types, some with very short shelf-lives, while ensuring that health workers were trained on each vaccine specificities, and that vaccines were delivered within their lifetime

Despite the challenges, the Ministry of Health with support from partners such as GAVI, UNICEF, the World Bank and WHO, has made great efforts to increase the vaccine uptake through expanding vaccination sites, ensuring effective use of available stocks, pacing delivery of new vaccine stocks, mobilizing communities and addressing doubts and misinformation, training health workers, and providing additional support for low-performing districts to increase vaccine uptake said Dr Janet Kayita, Acting WHO Representative in Malawi. WHO congratulates Malawi on this important milestone, and will continue to support the government and its partners to achieve its goals.

In Oct. 2021, a joint Ministry of Health (MoH) and WHO-led partner multi-agency mission comprising of WHO, UNICEF, JSI and Gavi examined the root causes for the slow COVID-19 vaccine uptake in Malawi and recommended strategies both supply and demand-side - to scale up the uptake.

To increase vaccine demand, the country has deployed different vaccine delivery strategies. Besides having fixed vaccination sites, the country has also adopted periodic mobile, outreach and door to door vaccination campaigns.

In November, 2021, Malawi government with support from UNICEF and technical support from WHO, launched a COVID-19 Vaccine Express Program to reach all parts of the country including the remotest of the rural locations where community settlements are high. Following the vaccine express program, the country registered an increase in uptake of vaccines by 61%.

In a sub-set of low-performing districts with a high burden of COVID-19, WHO with UNICEF and health partners are supporting the Ministry of Health to enhance support supervision and enhance demand for the COVID-19 vaccine. Through WHO technical and financial support, the Ministry of Health conducts community engagement initiatives that target village health committees, traditional and religious leaders. The aim of the engagements is to orient the key community influencers on COVID-19 vaccine messages that highlight health benefits of the vaccine. The orientation also aims at addressing misinformation, myths and misconceptions surrounding the COVID-19 vaccines.

WHO continues to support the country to scale up COVID-19 vaccine uptake, which will protect against severe forms of disease, hospitalization and the emergence of variants. WHO is also support efforts to step up surveillance, genome sequencing capacity, and increase testing to facilitate early detection and response to clusters of cases. Support for efforts to adhere to public health and social measures is also continuing

See the original post here:

Malawi marks one year of COVID-19 vaccination, 828, 080 people receive full dose - WHO | Regional Office for Africa

S.Africa’s Aspen to supply its own branded COVID-19 vaccine by June – Reuters

March 12, 2022

JOHANNESBURG, March 9 (Reuters) - South Africa's Aspen Pharmacare (APNJ.J) will start supplying its branded COVID-19 vaccine to African nations by June, its chief executive told Reuters on Wednesday, after the drugmaker reported a 37% rise in profit for the half-year to Dec. 31.

Its shares were up 5% by 1315 GMT, outpacing a 0.6% rise in the broader market index (.JALSH).

Aspen said on Tuesday it had struck a deal with Johnson & Johnson (JNJ.N) to package, sell and distribute the American group's COVID vaccines under the Aspenovax brand in Africa. read more

Register

The agreement paves the way for Aspen to supply the COVID-19 vaccine across Africa, which has by far the lowest vaccination rate in the world.

"We will be in a position to supply 35 million vaccine doses per month by June," CEO Stephen Saad said, adding that a part of that will still be contracted to J&J.

He said Aspenovax would lead to a "material jump" in its revenues and profits from next year starting July 2022.

In November 2020 J&J contracted Aspen to package the COVID-19 vaccine components into final vials, a process called fill and finish, and supply it back to J&J. Under the terms of the deal, Aspen is currently supplying 20 million doses per month to J&J.

Saad said the company would still only package the vaccine and will not produce the drug substance, which many South African health experts have said would be the next step for Aspen under its partnership with J&J.

"I think we want to see where the volumes go sustainably. If the volumes peak for a year or two and then go away, then I don't want to invest in something that has no demand in future," he said.

The company is increasing its vaccine capacity from roughly 450 million doses now to 750 million by February 2023. This could also be used to service cancer treatments or insulin which would give the company "broad access to emerging markets", he said.

($1 = 15.1579 rand)

Register

Reporting by Promit Mukherjee; Editing by Louise Heavens and Jan Harvey

Our Standards: The Thomson Reuters Trust Principles.

See the original post:

S.Africa's Aspen to supply its own branded COVID-19 vaccine by June - Reuters

‘Overwhelming’ Need to Study COVID Vaccine-Associated Tinnitus – Medscape

March 12, 2022

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.

It's now known that tinnitus may be an unexpected side effect of SARS-CoV-2 vaccination, and there is an urgent need to understand the precise mechanisms and best treatment for vaccine-associated tinnitus, researchers say.

As of mid-September 2021, 12,247 cases of tinnitus, or ringing in the ears, following COVID-19 vaccination have been reported to the Vaccine Adverse Event Reporting System of the US Centers for Disease Control and Prevention.

"Despite several cases of tinnitus being reported following SARS-CoV-2 vaccination, the precise pathophysiology is still not clear," write Syed Hassan Ahmed, third-year MBBS student, Dow University of Health Sciences, Karachi, Pakistan, and co-authors.

The researchers review what is known and unknown about SARS-CoV-2 vaccine-associated tinnitus in an article published online February 11 in Annals of Medicine and Surgery.

The researchers say cross-reactivity between anti-spike SARS-CoV-2 antibodies and otologic antigens is one possibility, based on the mechanisms behind other COVID-19 vaccine-induced disorders and the phenomenon of molecular mimicry.

"The heptapeptide resemblance between coronavirus spike glycoprotein and numerous human proteins further supports molecular mimicry as a potential mechanism behind such vaccine-induced disorders," they write.

Anti-spike antibodies may react with antigens anywhere along the auditory pathway and fuel an inflammatory reaction, they point out.

"Therefore, understanding the phenomenon of cross-reactivity and molecular mimicry may be helpful in postulating potential treatment behind not only tinnitus but also the rare events of vaccination associated hearing loss and other otologic manifestations," the authors say.

Genetic predispositions and associated conditions may also play a significant role in determining whether an individual develops vaccine-induced tinnitus.

Stress and anxiety following COVID vaccination may also play a role, inasmuch as anxiety-related adverse events following vaccination have been reported. Vaccine-related anxiety as a potential cause of tinnitus developing after vaccination needs to be explored, they write.

How best to manage COVID vaccine-associated tinnitus also remains unclear, but it starts with a well-established diagnosis, the authors say.

A well-focused and detailed history and examination are essential, with particular emphasis placed on preexisting health conditions, specifically, autoimmune diseases, such as Hashimoto thyroiditis; otologic conditions, such as sensorineural hearing loss; glaucoma; and psychological well-being. According to the review, patients often present with a history of one or more of these disorders.

"However, any such association has not yet been established and requires further investigation to be concluded as potential risk factors for vaccine-induced tinnitus," they caution.

Routine cranial nerve examination, otoscopy, Weber test, and Rinne test, which are used for tinnitus diagnosis in general, may be helpful for confirmation of vaccine-associated tinnitus.

Owing to the significant association between tinnitus and hearing impairment, audiology should also performed, the authors say.

Although treatments for non-vaccine-induced tinnitus vary significantly, corticosteroids are the top treatment choice for SARS-CoV-2 vaccine-induced tinnitus reported in the literature.

Trials ofother drug and nondrug interventions that may uniquely help with vaccine-associated tinnitus are urgently needed, the authors say.

Summing up, the reviewers say, "Although the incidence of COVID-19 vaccine-associated tinnitus is rare, there is an overwhelming need to discern the precise pathophysiology and clinical management as a better understanding of adverse events may help in encountering vaccine hesitancy and hence fostering the COVID-19 global vaccination program.

"Despite the incidence of adverse events, the benefits of the SARS-CoV-2 vaccine in reducing hospitalization and deaths continue to outweigh the rare ramifications," they conclude.

The research had no specific funding. The authors have disclosed no relevant financial relationships.

Ann Med Surg. Published online February 11, 2022. Full text

For more news, follow Medscape on Facebook, Twitter, Instagram, and YouTube.

Here is the original post:

'Overwhelming' Need to Study COVID Vaccine-Associated Tinnitus - Medscape

Page 269«..1020..268269270271..280290..»